Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 1 | uM | 7 | 1250.00 | 580.08 | 1943.00 | 1907.25 | 1.0187 | 1.0217 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1971.00 | 1907.25 | 1.0334 | 1.0387 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1605.00 | 1907.25 | 0.8415 | 0.8088 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 1250.00 | 580.08 | 567.00 | 1907.25 | 0.2973 | -0.0132 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 2064.00 | 1907.25 | 1.0822 | 1.0941 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2064.00 | 1907.25 | 1.0822 | 1.0941 | |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 2086.00 | 1907.25 | 1.0937 | 1.1071 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 1250.00 | 580.08 | 2051.00 | 1907.25 | 1.0754 | 1.0865 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1829.00 | 1907.25 | 0.9590 | 0.9518 |
| BT-20 | Linsitinib | 1 | uM | 7 | 1250.00 | 580.08 | 1732.00 | 1907.25 | 0.9081 | 0.8908 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1986.00 | 1907.25 | 1.0413 | 1.0477 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1739.00 | 1907.25 | 0.9118 | 0.8953 |
| BT-20 | 17-AAG | 1 | uM | 7 | 1250.00 | 580.08 | 615.00 | 1907.25 | 0.3225 | 0.0346 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2211.00 | 1907.25 | 1.1593 | 1.1797 | |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 2145.00 | 1907.25 | 1.1247 | 1.1416 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1664.00 | 1907.25 | 0.8725 | 0.8472 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1969.00 | 1907.25 | 1.0324 | 1.0375 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2.00 | 1907.25 | 0.0010 | -0.9632 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 2.00 | 4393.50 | 0.0005 | -0.9758 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4064.00 | 4393.50 | 0.9250 | 0.9125 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 1368.00 | 4393.50 | 0.3114 | 0.0239 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4367.00 | 4393.50 | 0.9940 | 0.9931 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3984.00 | 4393.50 | 0.9068 | 0.8908 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4745.00 | 4393.50 | 1.0800 | 1.0903 |
| BT-20 | Lapatinib | 10 | uM | 7 | 2500.00 | 1312.79 | 1525.00 | 4393.50 | 0.3471 | 0.0898 |